It’s a great idea to invest in us – and here’s why
Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany, Collaborates with Acceleration Consortium on ...
AI-driven experimentation planner BayBE (Bayesian Back End) by us and Acceleration Consortium is available open-source on GitHub
2023/12/06
-
Press Releases
MilliporeSigma Launches First Ever AI Solution to Integrate Drug Discovery ...
AIDDISON™ software-as-a-service platform bridges the gap between virtual molecule design and real-world manufacturing.
2023/12/05
-
Press Releases
Merck KGaA, Darmstadt, Germany Provides Update on Phase III Results for Evobrutinib ...
Two Phase III EVOLUTION clinical trials of evobrutinib did not meet their primary endpoints.
2023/12/05


Share Price
Check Share PriceShare Price

